European Pharmaceutical Review

NOVEMBER 16, 2022

To ensure people in LMICs have access to new and innovative medicines and vaccines as soon as possible after launch, companies need to have an access plan in place for products in the pipeline from at least Phase II of R&D. The research showed 83 percent of pharmaceutical companies are putting more strategies in place.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Communication 98

pharmaphorum

JULY 7, 2022

Read on to find out about reaching the gold standard of lung cancer screening, the promise of therapeutic cancer vaccines, why diversity is essential in oncology trials, and much more. Realising the promise of cancer vaccines. ASCO 2022: Checkpoint inhibitors, Enhertu in spotlight. Read Deep Dive: Oncology in full.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

DECEMBER 2, 2022

Frontiers Health 2022. Influencer culture has well and truly taken over the internet, with numerous benefits on offer for pharmaceutical companies in the healthcare influencer space. Company profile: Vinehealth. Case study: Syneos Health and VBI Vaccines. Read Deep Dive: Digital Health 2022 in full.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

pharmaphorum

MAY 5, 2021

Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world’s biggest-selling medicines. . The vaccine made $3.5 The vaccine made $3.5 Spending and profit from the vaccine are split equally between Pfizer and BioNTech.

Vaccines 105

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 105

PharmaShots

APRIL 12, 2023

The company's mRNA platform comprises advances across three components, i.e., mRNA, delivery, and the manufacturing process. Moderna's 2022 revenue increased by 0.04% vs. 2021. Merck KGaA's 2022 revenue depicted an inclination of 6.56% vs. 2021. Novo's 2022 revenue increased by 0.18% vs. 2021.

Vaccines 64

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 64

European Pharmaceutical Review

NOVEMBER 23, 2023

Boehringer Ingelheim is acquiring Swiss biotech T3 Pharmaceuticals AG (T3 Pharma), for up to £406 million (450 million CHF), boosting its immuno-oncology portfolio. There were a “record number of immuno-oncology approvals” in 2022, with 10 new innovative drugs being approved.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Immunization Vaccines 115

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. per 100,000 people were hospitalised for RSV-related reasons in the 2022–23 RSV season. per 100,000.

Vaccines 64

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 64

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

Pharmaceutical Technology

DECEMBER 22, 2022

Below you can find all the winners from the 2022 Excellence Awards which celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change. The company has founded a non-commercial Global Health Unit to meet these goals.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Insurance 52

Pharmaceutical Technology

DECEMBER 27, 2022

Once lockdown measures eased and Covid-19 vaccines and boosters became available, the industry anticipated a significant recovery in the market and in the number of deals. In 2022, Russia’s war on Ukraine struck the supply chain, eventually slowing manufacturing and causing shortages for multiple pharmaceutical companies.

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

pharmaphorum

FEBRUARY 16, 2022

Leela Barham and Neil Grubert look back at what was expected for market access in 2021 and look ahead at what 2022 could hold. Will all the efforts to speed up market access and ensure that the UK remains attractive to the life sciences industry post-Brexit pay off in 2022? 2022 will see both sides assessing scheme performance.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

PharmaShots

MAY 23, 2023

Was ranked the highest among the list of companies developing Cell & Gene therapy, followed by Novartis with a revenue of $50.54B and Spark Therapeutics with a revenue of $49.27B PharmaShots brings an informative report on the Top 20 Cell and Gene Therapy Companies based on the total Revenue generated in the year 2022 Total Revenue: $0.5M

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. Regulatory divergence became apparent in 2022 and could increase in 2023. Pharma’s starting to wake up to this.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

Fuld

NOVEMBER 1, 2022

BOSTON – Nov 1, 2022 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Brad Thompson to the role of Advisory Board Member. About Fuld & Company. www.fuld.com.

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Pharma Marketing Network

JANUARY 6, 2021

The use of artificial intelligence and machine learning will also increase in 2021 and is expected to become an $8 billion industry by 2022. The pharmaceutical industry is making it a high priority to be transparent with their audience and help their patients feel as comfortable as possible while getting the care they need.

Communication 98

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

JANUARY 30, 2023

However, two successive years of unusually high branded medicine sales figures, following the COVID-19 pandemic and a major post-lockdown surge in demand, have distorted the original model, causing a massive hike in payback rates, first capped at 15% in 2022, then jumping to 26.5% In 2022, a proposed payback figure of 19.1%

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Vaccines 97

pharmaphorum

APRIL 27, 2022

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine makers understandably soared early on, as clinical trials were started and completed in record time, giving hopes to millions of people in lockdown. Especially, women tend to have more distrust in pharmaceutical companies.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies 98

The Checkup by Singlecare

APRIL 16, 2024

It is a biologic medication and monoclonal antibody made by the pharmaceutical company Janssen Biotech. Avoid live vaccines while taking Stelara. Some examples of live vaccines include the measles, mumps, and rubella (MMR) vaccine, varicella, rotavirus, and nasal flu vaccine. How much does Stelara cost?

Dosage 98

Dosage Vaccines Immunization Insurance 98

European Pharmaceutical Review

FEBRUARY 3, 2025

In recent years, leading pharmaceutical companies, such as Sanofi, successfully launched smart factory programmes. About the authors Shidong Shi, PhD Head of Upstream Process Development, Altruist Biologics Dr Shi joined Altruist Biologics in 2022 in his current role. 2022; 78:102828. 2022; 414(2):969-991.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

pharmaphorum

JANUARY 16, 2023

Last year, IQVIA predicted that 2022 would be the crunch year for Alzheimer’s therapies: it is with a sense of déjà vu that the exact same prediction is contemplated for 2023. The European Medicine Agency-approved Biomarin’s Haemophilia A gene therapeutic, Roctavian, in 2022, and it is expected to be approved by the FDA in 2023.

FDA 98

FDA Pharmaceutical Companies Pharmaceutical Companies Compounding 98

STAT

NOVEMBER 18, 2022

… Pharmaceutical companies could be made to disclose prices and deals for products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord , Reuters reports.  A Or you may want to take stock of your life. But be safe. Enjoy, and see you soon.

FDA 98

FDA Documentation Compounding Pharmaceutical Companies 98

pharmaphorum

NOVEMBER 16, 2022

The 2022 edition of the Access to Medicine Index (ATMI) – which places the top 20 pharma companies for their efforts to improve delivery of medicines to lower income countries – sees GSK retain the number one position, newly joined by Johnson & Johnson in second and AstraZeneca in third. Jayasree Iyer.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Vaccines 105

STAT

JULY 6, 2023

On one side is the Pharmaceutical Care Management Association, the trade association representing pharmacy benefit managers, which argues that pharmaceutical companies are responsible for high drug prices. But overall, the industry is shedding jobs at a prodigious rate.

Vaccines 93

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 93

Pharmaceutical Technology

MAY 2, 2023

ODAIA will use the latest investment to further advance its artificial intelligence (AI)-powered product offerings, allowing the pharma companies to deliver various life changing therapies to the patients faster.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Vaccines 59

Roots Analysis

NOVEMBER 6, 2023

In this context, several industry players have demonstrated high inclination towards supporting and advancing the development of next generation RNA-based therapeutics, vaccine and technologies. The below given figure provides an illustrative summary of the benefits of next generation RNA-based vaccines and RNA-based therapeutics market.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

APRIL 12, 2023

Taiwan Shionogi, a subsidiary of the Japanese pharmaceutical company Shionogi, has filed an application with the Taiwan Food and Drug Administration (TFDA) to obtain emergency use authorisation (EUA) for ensitrelvir fumaric acid (ensitrelvir). It targets Covid-19 patients who were asymptomatic or only had mild symptoms.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 59

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.

Vaccines 64

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

NOVEMBER 4, 2022

BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose mRNA-based combination vaccine candidate against influenza and COVID-19 – a novel combination approach to help protect individuals against two severe respiratory viral diseases in one dose.

Vaccines 52

Vaccines Immunization FDA Pharmaceutical Companies 52

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Automation can be such a solution. Automation can be such a solution.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

Pharmaceutical Technology

DECEMBER 12, 2022

In this last 2022 edition of the series, which started in June , Pharmaceutical Technology is tracking major trial announcements and decisions by regulators and reimbursement agencies that have occurred since mid-October, as well as their potential impact on manufacturing plans. Source: GlobalData Pharmaceutical Intelligence Center.

Packaging 59

Packaging Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

PharmaShots

APRIL 13, 2023

model is a holistic approach to incorporate the same strategy to life science and pharmaceutical companies. A globally fast-growing, and largest pharmaceutical company in the world was created through a merger between Pfizer and Pharmacia. Model: Inspired by the industry 4.0 model, the pharma 4.0 compared to 2015.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40

Pharmaceutical Technology

NOVEMBER 11, 2022

According to an article in The Lancet, many African countries only received Covid-19 vaccines in December 2021, when many western countries had already rolled out initial vaccines and had begun to launch booster vaccines. We don't always get to see the best companies because we don't always know where to look.".

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 5, 2022

The pace of innovation in biopharma has rocketed over the last two years, with vaccines, new antivirals, and therapies delivered at an unprecedented pace. 1 Despite the increasing amount of venture capital flowing to biotech companies, total investments in such businesses nearly doubling between 2019 and 2021. March 2022. [2]

Vaccines 52

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

European Pharmaceutical Review

DECEMBER 12, 2023

Pharmaceutical companies such as Sanofi and AstraZeneca are currently conducting several high-potential clinical development programmes in oncology in collaboration with Innate Pharma. Detailed results from COAST were published in the Journal of Clinical Oncology in 2022.

Immunization 124

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies 124

pharmaphorum

APRIL 16, 2021

Even with the vaccine roll-out, further waves of COVID infection and lockdowns mean these vital drivers of launch performance remain impacted in 2021, and even beyond. Achievement, meaning commercial performance in the context of sales uptake, as measured by the IQVIA sales audits.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 95

Pharmaceutical Technology

MAY 29, 2023

The global pharmaceutical industry experienced an 18% drop in company filings mentions of orphan designated drugs in Q1 2023 compared with the previous quarter, with the highest share accounted for by Horizon Therapeutics with 50% year-on-year increase, according to GlobalData’s analysis of over 182 pharmaceutical company filings.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

Pharmaceutical Technology

DECEMBER 9, 2022

Rankings 2022. Pharmaceutical Technology Excellence Rankings – The Verdict. Solvias is a Swiss-based pharmaceutical company focused on contract research, development and manufacturing. Assays to support mRNA-based Covid-19 vaccines. Biopharmaceutical analytical services. HQ ADDRESS: Römerpark 2. Switzerland.

Vaccines 52

Vaccines Compounding FDA Packaging 52